Can Parkinson’s disease be cured by stimulating neurogenesis?

Por Foltynie, Thomas
Publicado no J Clin Invest (2015)

How common is dementia with Lewy bodies?

Por Barker, R, Foltynie, T
Publicado em 2003

Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment

Por Foltynie, Tom, Athauda, Dilan
Publicado no Mov Disord Clin Pract (2018)

Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson’s disease

Por Gratwicke, James P, Foltynie, Thomas
Publicado no Brain (2018)

Therapies to Slow, Stop, or Reverse Parkinson’s Disease

Por Foltynie, Tom, Langston, J. William
Publicado no J Parkinsons Dis (2018)

The genetic basis of Parkinson's disease

Por Foltynie, T, Sawcer, S, Brayne, C, Barker, R
Publicado em 2002

Parkinson’s disease dementia: a neural networks perspective

Por Gratwicke, James, Jahanshahi, Marjan, Foltynie, Thomas
Publicado no Brain (2015)

Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: The Effect of Varying Stimulation Parameters

Por Dayal, Viswas, Limousin, Patricia, Foltynie, Thomas
Publicado no J Parkinsons Dis (2017)

Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies

Por Kefalopoulou, Zinovia, Aviles-Olmos, Iciar, Foltynie, Thomas
Publicado em 2011

Understanding and Prevention of “Therapy-” Induced Dyskinesias

Por Aviles-Olmos, Iciar, Kefalopoulou, Zinovia, Foltynie, Thomas
Publicado em 2012

The Use of Deep Brain Stimulation in Tourette Syndrome

Por Akbarian-Tefaghi, Ladan, Zrinzo, Ludvic, Foltynie, Thomas
Publicado no Brain Sci (2016)

The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort

Por Foltynie, Thomas, Matthews, Fiona E, Ishihara, Lianna, Brayne, Carol
Publicado em 2006

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach

Por Lewis, S, Foltynie, T, Blackwell, A, Robbins, T, Owen, A, Barker, R
Publicado em 2005

Technologies Assessing Limb Bradykinesia in Parkinson’s Disease

Por Hasan, Hasan, Athauda, Dilan S., Foltynie, Thomas, Noyce, Alastair J.
Publicado no J Parkinsons Dis (2017)

Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson's Disease

Por Foley, Jennifer A., Foltynie, Tom, Limousin, Patricia, Cipolotti, Lisa
Publicado no Parkinsons Dis (2018)

Writer's Cramp as the First Symptom of Spinocerebellar Ataxia 14

Por Erro, Roberto, Cordivari, Carla, Edwards, Mark J., Foltynie, Thomas
Publicado no Mov Disord Clin Pract (2014)

IMPROVEMENT OF TICS AFTER SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION

Por Martinez-Torres, I, Hariz, M I., Zrinzo, L, Foltynie, T, Limousin, P
Publicado em 2009

Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series

Por Foltynie, T., Magee, C., James, C., Webster, G. J. M., Lees, A. J., Limousin, P.
Publicado em 2013

Apathy and Reduced Speed of Processing Underlie Decline in Verbal Fluency following DBS

Por Foley, Jennifer A., Foltynie, Tom, Zrinzo, Ludvic, Hyam, Jonathan A., Limousin, Patricia, Cipolotti, Lisa
Publicado no Behav Neurol (2017)

No Evidence for Association with Parkinson Disease for 13 Single-Nucleotide Polymorphisms Identified by Whole-Genome Association Screening

Por Goris, A., Williams-Gray, C. H., Foltynie, T., Compston, D. A. S., Barker, R. A., Sawcer, S. J.
Publicado em 2006